Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.10 USD
−520.50 M USD
288.35 M USD
59.25 M
About Ascendis Pharma A/S
Sector
CEO
Jan Møller Mikkelsen
Headquarters
Hellerup
Website
Founded
2006
FIGI
BBG007R7VNC1
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
